CDK4/6 Inhibition Enhances Oncolytic Virus Efficacy by Potentiating Tumor-Selective Cell Killing and T-cell Activation in Refractory Glioblastoma

Jingshu Xiao(Institute of Infection and Immunity), Deyin Guo(Sun Yat-sen University)
Cancer Research
July 6, 2022
Cited by 33


Related Papers